Adams Diversified Equity Fund’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Adams Diversified Equity Fund’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-4,600	Closed	-$111K	–	227
2019 Q2	$111K	Sell	4,600 -5,200	-53%	-$132K	0.01%	199
2019 Q1	$259K	Sell	9,800 -10,200	-51%	-$242K	0.01%	172
2018 Q4	$391K	Sell	20,000 -11,800	-37%	-$231K	0.02%	194
2018 Q3	$623K	Sell	31,800 -2,300	-7%	-$43.7K	0.03%	175
2018 Q2	$565K	Sell	34,100 -2,900	-8%	-$44.2K	0.03%	196
2018 Q1	$525K	Hold	37,000	–	–	0.03%	195
2017 Q4	$540K	Sell	37,000 -10,800	-23%	-$152K	0.03%	192
2017 Q3	$606K	Buy	+47,800	New	+$608K	0.03%	208
2017 Q2	–	Sell	-48,100	Closed	-$711K	–	228
2017 Q1	$711K	Buy	48,100 +17,600	+58%	+$285K	0.04%	200
2016 Q4	$493K	Buy	+30,500	New	+$553K	0.03%	208

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Adams Diversified Equity Fund's HZNP Position: Q3 2019 in Review

Adams Diversified Equity Fund sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2019, closing a stake of 4,600 shares — an estimated $111K sold.

Adams Diversified Equity Fund first reported a position in HZNP in Q4 2016 and held it in 10 quarters. The position peaked at $711K in Q1 2017. 264 funds tracked by Wall St. Rank hold HZNP as of Q3 2019.

Adams Diversified Equity Fund reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2019 after selling out during the quarter.
Adams Diversified Equity Fund sold 4,600 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2019, an estimated $111K.
Adams Diversified Equity Fund first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2016 and held it in 10 quarters.
Adams Diversified Equity Fund's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $711K in Q1 2017.
264 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2019.

Based on Adams Diversified Equity Fund's 13F filing for Q3 2019, filed 28 Oct 2019.